• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Total Environ . A cost-effective plan for global testing - An infection rate stratified, algorith guided, multiple-level, continuously pooled t

tetano

Editor, Senior Moderator
Sci Total Environ


. 2020 Dec 24;765:144251.
doi: 10.1016/j.scitotenv.2020.144251. Online ahead of print.
A cost-effective plan for global testing - An infection rate stratified, algorith guided, multiple-level, continuously pooled testing strategy


Tianshu Gu[SUP] 1 [/SUP], Lan Yao[SUP] 2 [/SUP], Xia Meng[SUP] 3 [/SUP], J Carolyn Graff[SUP] 4 [/SUP], Donald Thomason[SUP] 5 [/SUP], Jing Li[SUP] 6 [/SUP], Wei Dong[SUP] 6 [/SUP], Yan Jiao[SUP] 6 [/SUP], Lotfi Aleya[SUP] 7 [/SUP], Marcello Maida[SUP] 8 [/SUP], Cong-Yi Wang[SUP] 9 [/SUP], Barbara Zangerl[SUP] 10 [/SUP], Sem Genini[SUP] 11 [/SUP], Kunal Ray[SUP] 12 [/SUP], Emanuel Goldman[SUP] 13 [/SUP], Jiafu Ji[SUP] 14 [/SUP], Andrei V Alexandrov[SUP] 15 [/SUP], Dianjun Sun[SUP] 16 [/SUP], Weikuan Gu[SUP] 17 [/SUP], Yongjun Wang[SUP] 18 [/SUP]



Affiliations

Abstract

The most effective measure to prevent or stop the spread of infectious diseases is the early identification and isolation of infected individuals through comprehensive screening. At present, in the COVID-19 pandemic, such screening is often limited to isolated regions as determined by local governments. Screening of potentially infectious individuals should be conducted through coordinated national or global unified actions. Our current research focuses on using resources to conduct comprehensive national and regional regular testing with a risk rate based, algorithmic guided, multiple-level, pooled testing strategy. Here, combining methodologies with mathematical logistic models, we present an analytic procedure of an overall plan for coordinating state, national, or global testing. The proposed plan includes three parts 1) organization, resource allocation, and distribution; 2) screening based on different risk levels and business types; and 3) algorithm guided, multiple level, continuously screening the entire population in a region. This strategy will overcome the false positive and negative results in the polymerase chain reaction (PCR) test and missing samples during initial tests. Based on our proposed protocol, the population screening of 300,000,000 in the US can be done weekly with between 15,000,000 and 6,000,000 test kits. The strategy can be used for population screening for current COVID-19 and any future severe infectious disease when drugs or vaccines are not available.

Keywords: COVID-19; Coronavirus; Infection; Population; Screening; Test.
 
Back
Top Bottom